Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic? Tazza F, Lapucci C, Cellerino M, Boffa G, et al. J Neurol Sci 2021;427:117501.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tazza F, Lapucci C, Cellerino M, Boffa G, et al. Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic? J Neurol Sci 2021;427:117501.
PMID: 34044238